An in vivo study demonstrated that nootkatone effectively suppresses MAPK3 expression by activating the PI3K/Akt signaling pathway, thereby alleviating neuroinflammation and ameliorating symptoms in a rotenone-induced PD model [79,80]. This evidence concerns the gene AKT1 and Parkinson disease.